RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,152 | -3.9% | 23,289 | +14.8% | 0.00% | 0.0% |
| Q2 2023 | $26,173 | -4.7% | 20,289 | -2.4% | 0.00% | -50.0% |
| Q1 2023 | $27,452 | -19.7% | 20,797 | -8.8% | 0.00% | 0.0% |
| Q4 2022 | $34,200 | +80.0% | 22,800 | +39.9% | 0.00% | +100.0% |
| Q3 2022 | $19,000 | -20.8% | 16,300 | -23.5% | 0.00% | -50.0% |
| Q2 2022 | $24,000 | -62.5% | 21,300 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $64,000 | +14.3% | 21,300 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $56,000 | -30.9% | 21,300 | -34.1% | 0.00% | -33.3% |
| Q3 2021 | $81,000 | -15.6% | 32,300 | -26.3% | 0.01% | -14.3% |
| Q2 2021 | $96,000 | +62.7% | 43,800 | +153.2% | 0.01% | +40.0% |
| Q1 2021 | $59,000 | -16.9% | 17,300 | -14.8% | 0.01% | -28.6% |
| Q4 2020 | $71,000 | +36.5% | 20,300 | -7.2% | 0.01% | +16.7% |
| Q3 2020 | $52,000 | – | 21,870 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |